COMMUNIQUÉS West-GlobeNewswire

UPDATE - Melinta Therapeutics Announces Appointment of Bruce L. Downey to Board of Directors
31/10/2018
NEW HAVEN, Conn., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company discovering, developing and commercializing novel antibiotics to treat serious bacterial [...]
LHC Group Announces Third Quarter 2018 Financial Results
31/10/2018
Affirms Guidance and Expectations for 12% to 15% Adjusted Earnings Accretion from Almost Family Acquisition in 2018 LAFAYETTE, La., Oct. 31, 2018 (GLOBE NEWSWIRE) -- LHC Group, Inc. (NASDAQ: LHCG) announced its [...]
Galapagos reports initiation of PINTA Phase 2 trial with GLPG1205 in patients with Idiopathic Pulmonary Fibrosis (IPF)
31/10/2018
Mechelen, Belgium; 31 October 2018; 22:01 CET - Galapagos NV (Euronext & NASDAQ: GLPG) reports first dosing in the PINTA Phase 2 trial with its GPR84 antagonist GLPG1205 in patients with idiopathic pulmonary [...]
Forty Seven Inc. Announces Publication in The New England Journal of Medicine of 5F9 Phase 1b Clinical Data in Non-Hodgkin’s Lymphoma (NHL)
31/10/2018
Publication Reaffirms Therapeutic Potential of CD47 Inhibition as Novel Approach to Treating Cancer Enrollment Ongoing in Phase 2 Portion of Clinical Trial Evaluating 5F9 in Combination with Rituximab for Patients with [...]
PRA Health Sciences, Inc. Reports Third Quarter 2018 Results and Updates 2018 Guidance
31/10/2018
Net new business of $657.2 million; Net book-to-bill of 1.28 $717.6 million of revenue; 23.3% growth at actual foreign exchange rates and 24.0% growth on a constant currency basis $572.9 million of revenue excluding the [...]
With Recent Acquisitions, NewBridge Global Ventures Creates Impressive Offering - CFN Media
31/10/2018
Seattle, WA, Oct. 31, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication [...]
Reata Pharmaceuticals, Inc. to Report Third Quarter 2018 Financial Results and Provide an Update on Development Programs on Wednesday, November 7, 2018
31/10/2018
IRVING, Texas, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq: RETA), a clinical-stage biopharmaceutical company, today announced that the company will report third quarter 2018 financial results [...]
Ziopharm Oncology to Announce Third Quarter 2018 Financial Results, Host Conference Call Nov. 8
31/10/2018
BOSTON, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Ziopharm Oncology , Inc. (Nasdaq:ZIOP), today announced that management will host a conference call and webcast slide presentation on Thursday, Nov. 8, at 4:30 p.m. ET to [...]
AIT Therapeutics Schedules Fiscal Second Quarter 2019 Financial Results Conference Call and Webcast
31/10/2018
Call scheduled for Wednesday, November 14 at 4:30pm Eastern Time NEW YORK, Oct. 31, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (OTC: AITB), a clinical-stage medical device and biopharmaceutical company focused on [...]
Imagin Medical Receives Approximately $1 Million From Exercise of Warrants
31/10/2018
VANCOUVER, British Columbia and BOSTON, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) announced today that it has [...]
MacroGenics Announces Date of Third Quarter 2018 Financial Results Conference Call
31/10/2018
Rockville, MD, Oct. 31, 2018 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX) today announced that on Wednesday, November 7, 2018, the Company will release its financial results for the quarter ended September 30, [...]
Optinose to Report Third Quarter 2018 Financial Results and Corporate Updates on November 13, 2018
31/10/2018
Conference Call and Webcast Scheduled for Tuesday, November 13 at 8:00 a.m. Eastern Time YARDLEY, Pa., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by [...]
Apricus Biosciences Provides Corporate Update and Third Quarter 2018 Financial Results
31/10/2018
Company Merger with Seelos Therapeutics, Inc. Expected to Close in Fourth Quarter 2018 Apricus Shareholders Expected to Own ~15% of Estimated $94 Million Combined Company Valuation at Closing SAN DIEGO, Oct. 31, 2018 ( [...]
The Ensign Group Reports Third Quarter 2018 Results
31/10/2018
Conference Call and Webcast Scheduled for tomorrow, November 1, 2018 at 10:00 am PT MISSION VIEJO, Calif., Oct. 31, 2018 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group [...]
XBiotech Highlights Third Quarter Developments for 2018
31/10/2018
Company Provides Updated Overview including on its Clinical and Discovery Pipeline as well as Other Corporate Initiatives AUSTIN, Texas, Oct. 31, 2018 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) today provided an [...]
Aeterna Zentaris to Announce Third Quarter 2018 Financial and Operating Results on November 6, 2018
31/10/2018
CHARLESTON, S.C., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX: AEZS) will announce its third quarter 2018 financial and operating results after market close on Tuesday, November 6, 2018. [...]
Melinta Therapeutics Announces Appointment of Bruce L. Downey to Board of Directors
31/10/2018
NEW HAVEN, Conn., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company discovering, developing and commercializing novel antibiotics to treat serious bacterial [...]
ChromaDex to Report Third Quarter 2018 Financial Results on Wednesday, November 7, 2018
31/10/2018
LOS ANGELES, Oct. 31, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) announced that it will hold a conference call on Wed., Nov. 7, 2018 at 4:30 p.m. Eastern time to discuss its financial results for the third [...]
Chembio Diagnostics Announces Proposed Public Offering of Common Stock
31/10/2018
MEDFORD, N.Y., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (NASDAQ: CEMI) (“Chembio”), a provider of point-of-care diagnostic tests for infectious diseases, announced today that it has commenced an [...]

Pages